| Primary |
| Asthma |
25.0% |
| Bronchitis |
25.0% |
| Dyspnoea |
12.5% |
| Bronchospasm |
8.3% |
| Chronic Obstructive Pulmonary Disease |
8.3% |
| Bronchiectasis |
4.2% |
| Lung Disorder |
4.2% |
| Product Used For Unknown Indication |
4.2% |
| Renal Pain |
4.2% |
| Scan Myocardial Perfusion |
4.2% |
|
| Tachycardia Foetal |
9.5% |
| Agitation |
4.8% |
| Asthma |
4.8% |
| Atrial Tachycardia |
4.8% |
| Cardiac Failure |
4.8% |
| Cardiotoxicity |
4.8% |
| Hyperventilation |
4.8% |
| Lung Disorder |
4.8% |
| Memory Impairment |
4.8% |
| Pneumonia |
4.8% |
| Procedural Complication |
4.8% |
| Product Substitution Issue |
4.8% |
| Renal Failure |
4.8% |
| Respiratory Disorder |
4.8% |
| Skin Test Positive |
4.8% |
| Syncope |
4.8% |
| Tachycardia |
4.8% |
| Tachypnoea |
4.8% |
| Troponin Increased |
4.8% |
| Unresponsive To Stimuli |
4.8% |
|
| Secondary |
| Asthma |
31.1% |
| Product Used For Unknown Indication |
22.3% |
| Drug Use For Unknown Indication |
14.8% |
| Weight Decreased |
3.2% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Obesity |
2.9% |
| Pneumonia |
2.7% |
| T-cell Type Acute Leukaemia |
2.6% |
| Drug Exposure During Pregnancy |
2.0% |
| Status Asthmaticus |
2.0% |
| Bronchopulmonary Aspergillosis |
1.9% |
| Mesotherapy |
1.7% |
| Hypertension |
1.6% |
| Asthmatic Crisis |
1.3% |
| Cardiac Stress Test |
1.3% |
| Chest Pain |
1.3% |
| Scan Myocardial Perfusion |
1.3% |
| Blood Cholesterol Increased |
1.0% |
| Dizziness |
1.0% |
| Gout |
1.0% |
|
| Delirium |
15.0% |
| Tachycardia Foetal |
12.6% |
| Vomiting |
8.7% |
| Respiratory Failure |
7.9% |
| Status Epilepticus |
7.1% |
| Wheezing |
4.7% |
| Colitis Ischaemic |
3.9% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
3.9% |
| Supraventricular Tachycardia |
3.9% |
| Tension |
3.9% |
| Pyrexia |
3.1% |
| Renal Failure |
3.1% |
| Status Asthmaticus |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Tremor |
3.1% |
| Visual Impairment |
3.1% |
| Drug Toxicity |
2.4% |
| Ejection Fraction Decreased |
2.4% |
| Toe Amputation |
2.4% |
| White Blood Cell Count Increased |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.6% |
| Asthma |
18.6% |
| Product Used For Unknown Indication |
15.6% |
| Chronic Obstructive Pulmonary Disease |
6.3% |
| Pneumonia |
5.0% |
| Pulmonary Oedema |
4.9% |
| Hypertension |
3.6% |
| Rheumatoid Arthritis |
3.2% |
| Emphysema |
2.6% |
| Bronchitis Chronic |
2.3% |
| Anaesthesia |
1.8% |
| Dyspnoea |
1.7% |
| Infection |
1.6% |
| Lung Disorder |
1.5% |
| Cor Pulmonale Chronic |
1.4% |
| Diabetes Mellitus |
1.4% |
| Right Ventricular Failure |
1.4% |
| Prophylaxis |
1.3% |
| Cardiac Failure |
1.2% |
| Anaemia |
1.1% |
|
| Vomiting |
11.2% |
| Respiratory Failure |
9.7% |
| Wheezing |
7.5% |
| Death |
6.7% |
| Renal Failure Acute |
6.7% |
| Rash |
6.0% |
| White Blood Cell Count Increased |
5.2% |
| Pneumonia |
4.5% |
| Colitis |
3.7% |
| Convulsion |
3.7% |
| Hyperkalaemia |
3.7% |
| Metabolic Acidosis |
3.7% |
| Pancreatitis Acute |
3.7% |
| Pulmonary Oedema |
3.7% |
| Septic Shock |
3.7% |
| Small For Dates Baby |
3.7% |
| Trance |
3.7% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Malaise |
3.0% |
| Multi-organ Failure |
3.0% |
|
| Interacting |
| Parkinson's Disease |
100.0% |
|
| Respiratory Disorder |
100.0% |
|
